Real-time enrollment status for this mash - metabolic dysfunction-associated steatohepatitis clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:43 PM UTC
| NCT Number | NCT07335601 |
| Recruiting Status | Recruiting |
| Condition | MASH - Metabolic Dysfunction-Associated Steatohepatitis |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Madrigal Pharmaceuticals, Inc. |
| Last Updated on CT.gov | August 26, 2026 (Aug 26, 2026) |
As of October 12, 2026: Clinical trial NCT07335601 is currently recruiting participants. This phase2 study for mash - metabolic dysfunction-associated steatohepatitis is actively seeking new participants at 16 locations across the United States. The study is sponsored by Madrigal Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07335601 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07335601 was last updated Aug 26, 2026 (August 26, 2026). HelloStudys verifies this status automatically.